People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HistoSonics, Inc. | — | Other Health Care | Series D+ | $308.2M | $1.0B | 2018 |
| Amount, Inc. | — | Other Technology | Series C | $134.7M | $656.6M | 2022 |
Fred Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fred Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Carlborg | 1 | 14 |
| Nigel Morris | 1 | 9 |
| Robert Reynolds | 1 | 7 |
| V. Kadir Kadhiresan | 1 | 5 |
| Jon Freeman | 1 | 5 |
| Kevin Marcus | 1 | 5 |
| JOHN JOHNSTON | 1 | 5 |
| Linda Tufts | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Albert Goldstein | 1 | 4 |
| Kadir Kadhiresan | 1 | 4 |
| Michael Blue | 1 | 4 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Wen Chen | 1 | 3 |
| Rahul Gupta | 1 | 3 |
| Andrew Von Eschenbach | 1 | 3 |
| Richard Eric Bosler | 1 | 2 |
| Jim Adox | 1 | 2 |
| Robert Morff | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.